About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Destm1Cap
targeted mutation 1, Yassemi Capetanaki
MGI:2178321
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Destm1Cap/Destm1Cap involves: 129S7/SvEvBrd MGI:3773060
hm2
Destm1Cap/Destm1Cap involves: 129S7/SvEvBrd * C57BL/6 MGI:2178322
cx3
Destm1Cap/Destm1Cap
Tg(Bcl2)ACap/Tg(Bcl2)ACap
involves: 129S7/SvEvBrd * C57BL/6 MGI:3036355
cx4
Destm1Cap/Destm1Cap
Tg(Bcl2)BCap/Tg(Bcl2)BCap
involves: 129S7/SvEvBrd * C57BL/6 MGI:3036356


Genotype
MGI:3773060
hm1
Allelic
Composition
Destm1Cap/Destm1Cap
Genetic
Background
involves: 129S7/SvEvBrd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Destm1Cap mutation (0 available); any Des mutation (34 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Cardiac fibrosis and calcification seen in Destm1Cap/Destm1Cap mice is reduced in Destm1Cap/Destm1Cap Tg(Bcl2)ACap/Tg(Bcl2)ACap and Destm1Cap/Destm1Cap Tg(Bcl2)BCap/Tg(Bcl2)BCap mice

cardiovascular system
• cardiomyocytes show disrupted contractile apparatus and numerous mitochondrial abnormalities, including loss of positioning, proliferation, clumping, and formation of cleared areas around mitochondria, and individual mitochondria appear swollen and misshapen
• cardiac hypertrophy occurs in response to cardiac damage, with significant increase in heart size and distortion of the ventricles
• fibrosis associated with calcium deposits is found throughout the left ventricle
• impaired systolic function, showing decreased peak aortic velocity and mean acceleration
• cardiomyocyte mitochondria exhibit increased sensitivity to calcium induced swelling

muscle
• cardiomyocytes show disrupted contractile apparatus and numerous mitochondrial abnormalities, including loss of positioning, proliferation, clumping, and formation of cleared areas around mitochondria, and individual mitochondria appear swollen and misshapen
• impaired systolic function, showing decreased peak aortic velocity and mean acceleration

growth/size/body
• cardiac hypertrophy occurs in response to cardiac damage, with significant increase in heart size and distortion of the ventricles




Genotype
MGI:2178322
hm2
Allelic
Composition
Destm1Cap/Destm1Cap
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Destm1Cap mutation (0 available); any Des mutation (34 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Myocardium degeneration and calcification in Destm1Cap/Destm1Cap mice

mortality/aging
• 6% of homozygotes die suddenly before reaching 1 year of age

cardiovascular system
• loss of myocardial fiber tension (J:35123)
• interstitial fibrosis and necrosis (J:35123)
• detachment of fibers from the sarcolemma (J:35123)
• disorganized mitochondria (J:35123)
• a 24% increase in average cell volume of ventricular myocytes at 7 months, with no changes in cell length or profile area (J:59831)
• loss of lateral alignment (J:35123)
• areas of disorganized and ragged myocytes, as commonly observed in hypertrophic myocardium (J:59831)
• moderate to severe thinning of myocardial wall after sudden death
• mild heart enlargement is frequently observed in the absence of stress
• severe heart enlargement is noted after sudden death or after exercise-induced stress
• prominent heart enlargement and ventricular dilation also observed in aging homozygotes
• a 20% increase in HW/BW ratio by 1 month of age or later
• concentric cellular hypertrophy of ventricular myocytes, with normal major diameters but a 30% increase in minor diameters at 7 months
• changes in expression pattern of hypertrophic markers associated with pressure overload hypertrophy at 1 and 6 months
• slight dilation of left ventricle in the absence of stress, with no severe changes in myocardial wall thickness
• severe dilation of the left ventricle after sudden death, with moderate to severe thinning of myocardial wall
• slight dilation of right ventricle in the absence of stress, with no severe changes in myocardial wall thickness
• severe dilation of the right ventricle after sudden death, with moderate to severe thinning of myocardial wall
• progressive calcification and degeneration, particularly of the left ventricle, evident by 3 weeks of age (J:35123)
• calcified lesions and areas of fibrous replacement of myocardial tissue as early as 1 week after birth; most prominent in the right ventricle and toward the inner and outer surfaces of the myocardium (J:59831)
• significantly impaired systolic function (reduced peak aortic flow velocity and average aortic acceleration) at 13-14 months of age, with a 20% reduction in peak aortic flow velocity evident at 3-13 months or later
• enhanced diastolic function at 3 months of age (increased ratios of E/A peak velocities and areas), no longer evident after 13 months
• progressive calcification and degeneration, particularly of the left ventricle, evident by 3 weeks of age
• lesions appeared to progress from the exterior of the myocardium inward

muscle
• loss of myocardial fiber tension (J:35123)
• interstitial fibrosis and necrosis (J:35123)
• detachment of fibers from the sarcolemma (J:35123)
• disorganized mitochondria (J:35123)
• a 24% increase in average cell volume of ventricular myocytes at 7 months, with no changes in cell length or profile area (J:59831)
• loss of lateral alignment (J:35123)
• areas of disorganized and ragged myocytes, as commonly observed in hypertrophic myocardium (J:59831)
• moderate to severe thinning of myocardial wall after sudden death
• significantly impaired systolic function (reduced peak aortic flow velocity and average aortic acceleration) at 13-14 months of age, with a 20% reduction in peak aortic flow velocity evident at 3-13 months or later
• enhanced diastolic function at 3 months of age (increased ratios of E/A peak velocities and areas), no longer evident after 13 months
• progressive calcification and degeneration, particularly of the left ventricle, evident by 3 weeks of age
• lesions appeared to progress from the exterior of the myocardium inward
• similar abnormalities as observed in cardiac muscle, but to a lesser extent
• ragged, disorganized fibers with a loss of tension
• disorganized mitochondria
• increased severity of myofibril defects in muscles with high usage (e.g. tongue muscle)
• defects similar to those observed in striated muscle, but less severe
• degeneration of striated muscle
• more severe in cardiac muscle

behavior/neurological
• noted by 2 weeks of age
• 50% of homozygotes show impaired excercise capacity and die during swimming

homeostasis/metabolism
• 50% of homozygotes show impaired excercise capacity and die during swimming

growth/size/body
• mild heart enlargement is frequently observed in the absence of stress
• severe heart enlargement is noted after sudden death or after exercise-induced stress
• prominent heart enlargement and ventricular dilation also observed in aging homozygotes
• a 20% increase in HW/BW ratio by 1 month of age or later
• concentric cellular hypertrophy of ventricular myocytes, with normal major diameters but a 30% increase in minor diameters at 7 months
• changes in expression pattern of hypertrophic markers associated with pressure overload hypertrophy at 1 and 6 months

cellular




Genotype
MGI:3036355
cx3
Allelic
Composition
Destm1Cap/Destm1Cap
Tg(Bcl2)ACap/Tg(Bcl2)ACap
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Destm1Cap mutation (0 available); any Des mutation (34 available)
Tg(Bcl2)ACap mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Cardiac fibrosis and calcification seen in Destm1Cap/Destm1Cap mice is reduced in Destm1Cap/Destm1Cap Tg(Bcl2)ACap/Tg(Bcl2)ACap and Destm1Cap/Destm1Cap Tg(Bcl2)BCap/Tg(Bcl2)BCap mice

cardiovascular system
N
• the progressive calcification and degeneration observed in Destm1Cap homozygotes is ameliorated
• some fibrosis is observed, althought there are fewer and smaller fibrotic lesions than in Destm1Cap homozygotes
• more fibrosis than with similar mice carrying the Tg(Bcl2)BCap, which overexpresses higher levels of BCL2
• some calcification is observed, although much less than in Destm1Cap homozygotes
• more calcification than with similar mice carrying the Tg(Bcl2)BCap, which overexpresses higher levels of BCL2

cellular
• some fibrosis is observed, althought there are fewer and smaller fibrotic lesions than in Destm1Cap homozygotes
• more fibrosis than with similar mice carrying the Tg(Bcl2)BCap, which overexpresses higher levels of BCL2




Genotype
MGI:3036356
cx4
Allelic
Composition
Destm1Cap/Destm1Cap
Tg(Bcl2)BCap/Tg(Bcl2)BCap
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Destm1Cap mutation (0 available); any Des mutation (34 available)
Tg(Bcl2)BCap mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Cardiac fibrosis and calcification seen in Destm1Cap/Destm1Cap mice is reduced in Destm1Cap/Destm1Cap Tg(Bcl2)ACap/Tg(Bcl2)ACap and Destm1Cap/Destm1Cap Tg(Bcl2)BCap/Tg(Bcl2)BCap mice

cardiovascular system
N
• the progressive calcification and degeneration observed in Destm1Cap homozygotes is ameliorated
• although cadiomyocytes show a significant improvement from the damage seen in Destm1Cap homozygotes, some cardiomyocytes exhibit a loss of mitochondria alignment
• some fibrosis is observed, although there are fewer and smaller fibrotic lesions than in both Destm1Cap homozygotes and Destm1Cap homozygotes carrying Tg(Bcl2)ACap
• some calcification is observed, althogh less than in both Destm1Cap homozygotes and Destm1Cap homozygotes carrying Tg(Bcl2)ACap

muscle
• although cadiomyocytes show a significant improvement from the damage seen in Destm1Cap homozygotes, some cardiomyocytes exhibit a loss of mitochondria alignment

cellular
• some fibrosis is observed, although there are fewer and smaller fibrotic lesions than in both Destm1Cap homozygotes and Destm1Cap homozygotes carrying Tg(Bcl2)ACap





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory